Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Impac Mortgage | OTC Markets | Financials | Banking Services | $1.83M | -0.1x | -0 | $0.05 | 58.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
51Talk Online Education DRC | NYSE | Academic & Educational Services | Miscellaneous Educational Service Providers | $86.22M | -5.5x | 0.17 | $14.98 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alimera | NASDAQ | Healthcare | Pharmaceuticals | $302.38M | -18x | -0.22 | $5.56 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.1% Downside | Upgrade to Pro+ | |
Finance of America Companies | NYSE | Financials | Investment Banking & Investment Services | $102.34M | -6.9x | 0.04 | $10.31 | 5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.9% Upside | Upgrade to Pro+ | |
Kuros Biosciences | OTC Markets | Healthcare | Biotechnology & Medical Research | $743.98M | -55x | -2.25 | $19.43 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cypherpunk Holdings | OTC Markets | Financials | Investment Banking & Investment Services | $16.15M | -14.7x | -0.23 | $0.11 | 37.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alnylam | NASDAQ | Healthcare | Biotechnology & Medical Research | $31.68B | -426.8x | -4.66 | $246.78 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.5% Upside | Upgrade to Pro+ | |
Leopard Energy | OTC Markets | Technology | Software & IT Services | $229.13K | -0.9x | -0.01 | $0.18 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Delcath Systems | NASDAQ | Healthcare | Healthcare Equipment & Supplies | $270.76M | -4.1x | -0.21 | $9.67 | -7.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Soluna Holdings Prf A | NASDAQ | Technology | Software & IT Services | $19.28M | -0.3x | $5.11 | -7.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Mentor Capital, Inc. | OTC Markets | Financials | Investment Banking & Investment Services | $1.92M | 0.7x | -0 | $0.08 | -17% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Arcutis | NASDAQ | Healthcare | Biotechnology & Medical Research | $1.21B | -5.3x | -0.1 | $10.36 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Comstock Mining | NYSE Amex | Basic Materials | Metals & Mining | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||||||
Earlyworks ADR | NASDAQ | Technology | Software & IT Services | $7.06M | -3.5x | -0.17 | $2.34 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Arcellx | NASDAQ | Healthcare | Biotechnology & Medical Research | $3.83B | -55.8x | -0.97 | $71.25 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.7% Upside | Upgrade to Pro+ | |
TG | NASDAQ | Healthcare | Biotechnology & Medical Research | $3.16B | 33.2x | 0.22 | $22.03 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chimera Investment | NYSE | Real Estate | Residential & Commercial REITs | $1.24B | 8.6x | 0.03 | $15.44 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2% Upside | Upgrade to Pro+ | |
KKR Real Estate | NYSE | Real Estate | Residential & Commercial REITs | $842.40M | 59.7x | 0.52 | $12.15 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7% Upside | Upgrade to Pro+ | |
DeFi Tech | OTC Markets | Financials | Banking Services | $515.82M | 12.3x | 0.05 | $1.73 | -8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kronos Bio | NASDAQ | Healthcare | Biotechnology & Medical Research | $59.36M | -0.6x | -0.03 | $0.99 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biostem Tech | OTC Markets | Healthcare | Pharmaceuticals | $156.36M | 1,162.7x | 9.69 | $9.57 | -5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ngx Energy International | OTC Markets | Energy | Oil & Gas | $168.09M | -2.5x | 0.02 | $0.78 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pinetree Capital | OTC Markets | Financials | Investment Banking & Investment Services | $48.46M | 4.9x | 0.02 | $5.13 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Perspective Therapeutics | NYSE | Healthcare | Biotechnology & Medical Research | $1.03B | -11.1x | 0.44 | $15.26 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.4% Upside | Upgrade to Pro+ | |
Castle Biosciences | NASDAQ | Healthcare | Healthcare Equipment & Supplies | $813.24M | -259.6x | -2.72 | $29.32 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.4% Upside | Upgrade to Pro+ | |
Axsome Therapeutics Inc | NASDAQ | Healthcare | Pharmaceuticals | $4.47B | -14.5x | 0.28 | $93.19 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.4% Upside | Upgrade to Pro+ | |
Glassbridge Enterprises | OTC Markets | Financials | Investment Banking & Investment Services | $629.25K | -0.2x | 0 | $25 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rhythm Pharma | NASDAQ | Healthcare | Biotechnology & Medical Research | $3.01B | -11.3x | 0.35 | $49.25 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.7% Upside | Upgrade to Pro+ | |
Global Net Lease | NYSE | Real Estate | Residential & Commercial REITs | $2.01B | -6.2x | 0.03 | $8.75 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.3% Upside | Upgrade to Pro+ | |
BeiGene ADS | NASDAQ | Healthcare | Biotechnology & Medical Research | $20.33B | -39x | -0.56 | $191.32 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.4% Upside | Upgrade to Pro+ |